Travoprost class of drug?

Travoprost is a prostaglandin F2α analog—specifically a synthetic prostaglandin analogue used to lower intraocular pressure in glaucoma and ocular hypertension.

| Category | Details |
|----------|---------|
| Drug class | Ophthalmic prostaglandin analog (PGF₂α analog) |
| Common brand name | Travatan® (travoprost) |
| Mechanism of action | Increases uveoscleral outflow of aqueous humor, reducing intra‑ocular pressure. It binds to prostanoid FP receptors in the eye. |
| Indications | Primary open‑angle glaucoma, ocular hypertension, and sometimes normal‑tension glaucoma. |
| Administration | Typically 1–2 drops in the affected eye(s) once nightly (often at bedtime). |
| Typical dosing | 0.004% (travoprost 0.004% solution). |
| Common side effects | Conjunctival hyperemia, eye redness, eyelash growth, iris color change (brown/black), mild burning/itching. |
| Contraindications | Known hypersensitivity to travoprost or any component of the formulation; concurrent use of other topical prostaglandin analogues (unless indicated for combination therapy). |
| Drug interactions | Generally minimal systemic interactions; avoid using other topical prostaglandins on the same eye without a wash‑out period. |

Quick Takeaway

Travoprost belongs to the prostaglandin analog class of eye drops that lower eye pressure by stimulating outflow through the uveoscleral pathway. It’s one of the first‑line agents for glaucoma management and is often chosen for its once‑daily dosing and good tolerability profile.